ArticleInternal and emergency medicine2022
Prevalence of symptoms in 1512 COVID-19 patients: have dizziness and vertigo been underestimated thus far?
Article in Internal and emergency medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 57 citations in OpenAlex.
- Baseline cohort profile: clinical and molecular characterisation of SARS-CoV-2 infected patients recruited into a longitudinal COVID-19 cohort study (COVGEN) in Malaysia.BMC infectious diseases · 2026Article
- Assessment of vertigo and dizziness in individuals following COVID-19.Irish journal of medical science · 2025Article
- Post-COVID-19 dizziness associated with a patulous eustachian tube.BMJ case reports · 2025Article
- An Analysis Between Body Composition and Vertigo Post-Coronavirus Disease 2019 Patients.International archives of otorhinolaryngology · 2025Article
- Significance of Neurological Manifestations and Their Association With Clinical Outcomes in Hospitalized COVID-19 Patients in Bandar Abbas, Iran: A Cross-Sectional Study.Health science reports · 2025Article
- Evaluation of the Peripheral and Central Auditory Systems in Children and Adolescents Before and After COVID-19 Infection.Children (Basel, Switzerland) · 2024Article
- Prognostic Factors in Idiopathic Sudden Sensorineural Hearing Loss: The Experience of Two Audiology Tertiary Referral Centres.Medicina (Kaunas, Lithuania) · 2024Article
- Sudden Sensorineural Hearing Loss in Patients Aged from 15 to 40 Years.Journal of clinical medicine · 2024Article
- Peripheral and brainstem auditory evaluation in post-COVID-19 individuals.Clinics (Sao Paulo, Brazil) · 2024Article
- Analysis of characteristics of and risk factors for otological symptoms after COVID-19 infection.PloS one · 2024Article
- Number of initial symptoms of SARS-CoV-2 infection is associated with the risk of otological symptoms: a retrospective study.BMC infectious diseases · 2023Article
- Predictors of Dizziness and Hearing Disorders in People with Long COVID.Medicina (Kaunas, Lithuania) · 2023Article
- Balance Disorders in People with History of COVID-19 in Light of Posturographic Tests.Journal of clinical medicine · 2023Article
- Vocal fatigue perceived in remote working by teachers of different school grades during COVID-19 pandemic.Auris, nasus, larynx · 2023Article
- COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters.International journal of molecular sciences · 2023Review
- The Prevalence of Dizziness and Vertigo in COVID-19 Patients: A Systematic Review.Brain sciences · 2022Review
- Audiological and vestibular symptoms following SARS-CoV-2 infection and COVID-19 vaccination in children aged 5-11 years.American journal of otolaryngologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The relationship between SARS-CoV-2 infection and dizziness is still unclear. The aim of this study is to assess the prevalence and characteristics of dizziness and vertigo among patients with mild-to-moderate COVID-19. Patients discharged from the emergency rooms with a confirmed SARS-CoV-2 diagnosis were assisted by daily telephone calls until nasopharyngeal swab negativization, and specific symptoms concerning balance disorders were investigated through targeted questions posed by experienced physicians. The study included 1512 subjects (765 females, 747 males), with a median age of 51 ± 18.4 years. New-onset dizziness was reported by 251 (16.6%) patients, among whom 110 (43.8%) complained of lightheadedness, 70 (27.9%) of disequilibrium, 41 (16.3%) of presyncope, and 30 (12%) of vertigo. This study analyzed in detail the prevalence and pathophysiological mechanisms of the different types of balance disorders in a large sample, and the results suggest that dizziness should be included among the main symptoms of COVID-19 because one-sixth of patients reported this symptom, with females being significantly more affected than males (20.3 vs 12.9%, P < 0.001). Most cases of dizziness were attributable to lightheadedness, which was probably exacerbated by psychophysical stress following acute infection and mandatory quarantine. Vertigo should not be underestimated because it might underlie serious vestibular disorders, and disequilibrium in elderly individuals should be monitored due to the possible risk of falls.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.